---
schema_version: "secwatch.filing_event.v1"
accession: "0001520138-24-000045"
form_type: "8-K"
ticker: "BIVI"
cik: "0001580149"
company_name: "BIOVIE INC."
filed_at: "2024-01-25T23:59:59+00:00"
generated_at: "2026-06-06T18:19:03.109333+00:00"
event_type: "litigation"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# BioVie hit with shareholder class action over NE3107 trial disclosures

## Summary
- Lawsuit filed Jan 19, 2024 in Nevada federal court (Olmstead v. BioVie Inc., No. 3:24-cv-00035).
- Alleges material misrepresentations/omissions about NE3107 study and trial under Sections 10(b) and 20(a).
- Class period: Aug 5, 2021 through Nov 29, 2023; seeks unspecified monetary damages and fees.
- Company believes lawsuit is without merit and intends to defend vigorously.

## SEC filing metadata
- accession: 0001520138-24-000045
- form_type: 8-K
- ticker: BIVI
- cik: 0001580149
- company_name: BIOVIE INC.
- filed_at: 2024-01-25T23:59:59+00:00
- event_type: litigation
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1580149/000152013824000045/0001520138-24-000045-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1580149/000152013824000045/bivi-20240119_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001520138-24-000045
- JSON: https://secwatch.observer/filing/0001520138-24-000045.json
- Plain text: https://secwatch.observer/filing/0001520138-24-000045.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.